Specialty Pharmacy

Study finds Vimpat 'significantly' reduces partial-onset seizures

Mar 10, 2010

An investigational drug can reduce seizures in adolescents and adults with...

Abbott to boost business with Facet acquisition

Mar 09, 2010

Abbott will acquire Facet Biotech for $450 million, the drug maker...

Decision Resources: Acute migraine therapy designed for vascular disease patients will capture market share

Mar 09, 2010

A company that develops a drug for acute migraines in pill form that doesn...

FDA committee recommends approval for InterMune’s Esbriet

Mar 09, 2010

A Food and Drug Administration committee has recommended approval for an...

Bristol-Myers Squibb, Isis announce partnership for cholesterol drug

Mar 07, 2010

Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone...

Clinical study: Pfizer-Bristol anticoagulant more effective than competitior

Mar 07, 2010

A pill-based anticoagulant drug under development by Pfizer and Bristol-...

Genzyme, PTC: Mid-stage trial for DBMD treatment yields mixed results

Mar 07, 2010

A mid-stage clinical trial of a drug for muscular dystrophy got mixed...

SPECIALTY PHARMACY ROUNDTABLE

The Drug Store News Group/Specialty Pharmacy magazine hosted an exclusive executive roundtable discussion of leading specialty pharmacy providers. Click here for a PDF of their discussion, including channel management strategies, accountable care organizations and the importance of technology.